24 related articles for article (PubMed ID: 36849535)
21. Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors.
Isoyama S; Tamaki N; Noguchi Y; Okamura M; Yoshimatsu Y; Kondo T; Suzuki T; Yaguchi SI; Dan S
Cell Death Dis; 2023 Feb; 14(2):169. PubMed ID: 36849535
[TBL] [Abstract][Full Text] [Related]
22. Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway.
van Maldegem AM; Bovée JV; Peterse EF; Hogendoorn PC; Gelderblom H
Eur J Cancer; 2016 Jan; 53():171-80. PubMed ID: 26765686
[TBL] [Abstract][Full Text] [Related]
23. Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations.
Fisher C
Virchows Arch; 2010 Feb; 456(2):153-66. PubMed ID: 19396640
[TBL] [Abstract][Full Text] [Related]
24. Combinatorial strategies to potentiate the efficacy of HDAC inhibitors in fusion-positive sarcomas.
Lanzi C; Cassinelli G
Biochem Pharmacol; 2022 Apr; 198():114944. PubMed ID: 35152144
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]